exchange is out of whack with the true value of the company.
It appears to me that their land holdings are understated.
They could be listed at cost, not current value. The company
has done nothing to attract investors over the years. They
don't issue press releases, or promote the stock in any fashion.
The lack of trading is a result. Still, if insiders are willing
to pluck down .05 for it in an illiquid market, eventually
something will happen. The current market cap is only about
3 million, I can't see how the co wouldn't get 2-3x that much
at least in any sale. The stock should be trading over .10
as a floor, not where it is.
Recent PRKA News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:22:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 10:23:59 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/27/2024 10:20:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/26/2024 10:02:53 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/21/2024 11:04:56 AM
- Form DEFC14A - Definitive proxy statement, contested solicitations • Edgar (US Regulatory) • 02/16/2024 10:32:07 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/16/2024 09:36:36 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/13/2024 09:58:23 PM
- Form DEFC14A - Definitive proxy statement, contested solicitations • Edgar (US Regulatory) • 02/12/2024 10:08:54 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/12/2024 01:27:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 01:24:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:34:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:33:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:32:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:29:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:28:48 AM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/02/2024 03:31:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/01/2024 10:16:30 PM
- Form PREC14A - Preliminary proxy statements, contested solicitations • Edgar (US Regulatory) • 02/01/2024 10:09:19 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:59:36 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/29/2024 10:05:14 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/29/2024 10:03:31 PM
- Form DEFC14A - Definitive proxy statement, contested solicitations • Edgar (US Regulatory) • 01/26/2024 10:02:13 PM
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 01/22/2024 09:20:27 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM